CDC vaccine advisers are meeting today to review six “rare and severe” blood clot cases among more than 6.8 million Americans who received the Johnson & Johnson vaccine.
The FDA and CDC have recommended pausing use of the vaccine while it is being reviewed.
KDKA Health Editor Dr. Maria Simbra is talking to local doctors about clotting cases and the Johnson & Johnson COVID-19 vaccine.
Johnson & Johnson will delay the rollout of their COVID-19 vaccine in Europe following reports of blood clots in six people..
